Long-term Effect of Bariatric Surgery on Liver Enzymes in the Swedish Obese Subjects (SOS) Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Apr 5

PMID 23555982

Citations 32

Authors

Maria Antonella Burza

Stefano Romeo

Anna Kotronen

Per-Arne Svensson

Kajsa Sjoholm

Jarl S Torgerson

Anna-Karin Lindroos

Lars Sjostrom

Lena M S Carlsson

Markku Peltonen

Affiliations

Soon will be listed here.

Abstract

Background And Aim: Obesity is associated with elevated serum transaminase levels and non-alcoholic fatty liver disease and weight loss is a recommended therapeutic strategy. Bariatric surgery is effective in obtaining and maintaining weight loss. Aim of the present study was to examine the long-term effects of bariatric surgery on transaminase levels in obese individuals.

Methods: The Swedish Obese Subjects (SOS) study is a prospective controlled intervention study designed to compare the long-term effects of bariatric surgery and usual care in obese subjects. A total of 3,570 obese participants with no excess of alcohol consumption at baseline (1,795 and 1,775 in the control and surgery group, respectively) were included in the analyses. Changes in transaminase levels during follow-up were compared in the surgery and control groups.

Results: Compared to usual care, bariatric surgery was associated with lower serum ALT and AST levels at 2- and 10- year follow up. The reduction in ALT levels was proportional to the degree of weight loss. Both the incidence of and the remission from high transaminase levels were more favorable in the surgery group compared to the control group. Similarly, the prevalence of ALT/AST ratio <1 was lower in the surgery compared to the control group at both 2- and 10-year follow up.

Conclusions: Bariatric surgery results in a sustained reduction in transaminase levels and a long-term benefit in obese individuals.

Citing Articles

Postoperative Biochemical Outcomes in Metabolic Bariatric Surgery: Results from a High-Adherence Cohort.

Sofia M, Agosta M, DAmato S, Conti G, Mazzone C, Faletra G J Pers Med. 2025; 15(1.

PMID: 39852200 PMC: 11766610. DOI: 10.3390/jpm15010007.

Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment.

Patel A, Peddu D, Amin S, Elsaid M, Minacapelli C, Chandler T J Clin Transl Hepatol. 2023; 11(2):502-515.

PMID: 36643037 PMC: 9817050. DOI: 10.14218/JCTH.2022.00204.

The Effect of Laparoscopic Sleeve Gastrectomy and Gastric Bypass Surgery on Non-Alcoholic Steatohepatitis in Iranian Patients with Obesity.

Elyasinia F, Jalali S, Zarini S, Sadeghian E, Sorush A, Pirouz A Middle East J Dig Dis. 2023; 13(3):200-207.

PMID: 36606220 PMC: 9489465. DOI: 10.34172/mejdd.2021.226.

Type 2 deiodinase p.Thr92Ala polymorphism does not affect the severity of obesity and weight loss after bariatric surgery.

Benenati N, Bufano A, Cantara S, Ricci C, Marzocchi C, Ciuoli C Sci Rep. 2022; 12(1):10643.

PMID: 35739305 PMC: 9226046. DOI: 10.1038/s41598-022-14863-x.

Diagnostic and Therapy of Nonalcoholic Fatty Liver Disease: A Narrative Review.

Roeb E Visc Med. 2022; 38(2):126-132.

PMID: 35614896 PMC: 9082206. DOI: 10.1159/000519611.

References

Angulo P, Keach J, Batts K, Lindor K . Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999; 30(6):1356-62. DOI: 10.1002/hep.510300604. View

Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R . Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009; 137(2):532-40. DOI: 10.1053/j.gastro.2009.04.052. View

Siest G, Schiele F, Galteau M, Panek E, Steinmetz J, Fagnani F . Aspartate aminotransferase and alanine aminotransferase activities in plasma: statistical distributions, individual variations, and reference values. Clin Chem. 1975; 21(8):1077-87. View

Wanless I, Lentz J . Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990; 12(5):1106-10. DOI: 10.1002/hep.1840120505. View

Pontiroli A, Pizzocri P, Librenti M, Vedani P, Marchi M, Cucchi E . Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab. 2002; 87(8):3555-61. DOI: 10.1210/jcem.87.8.8708. View

Sjostrom L, Narbro K, Sjostrom C, Karason K, Larsson B, Wedel H . Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357(8):741-52. DOI: 10.1056/NEJMoa066254. View

Mathurin P, Gonzalez F, Kerdraon O, Leteurtre E, Arnalsteen L, Hollebecque A . The evolution of severe steatosis after bariatric surgery is related to insulin resistance. Gastroenterology. 2006; 130(6):1617-24. DOI: 10.1053/j.gastro.2006.02.024. View

Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, Komesidou V . Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg. 2005; 15(8):1154-60. DOI: 10.1381/0960892055002239. View

Adams L, Lymp J, Sauver J, Sanderson S, Lindor K, Feldstein A . The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005; 129(1):113-21. DOI: 10.1053/j.gastro.2005.04.014. View

10.

Clark J, Brancati F, Diehl A . The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003; 98(5):960-7. DOI: 10.1111/j.1572-0241.2003.07486.x. View

11.

Ekstedt M, Franzen L, Mathiesen U, Thorelius L, Holmqvist M, Bodemar G . Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006; 44(4):865-73. DOI: 10.1002/hep.21327. View

12.

Chavez-Tapia N, Tellez-Avila F, Barrientos-Gutierrez T, Mendez-Sanchez N, Lizardi-Cervera J, Uribe M . Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database Syst Rev. 2010; (1):CD007340. PMC: 7208314. DOI: 10.1002/14651858.CD007340.pub2. View

13.

Torgerson J, Lindroos A, Sjostrom C, Olsson R, Lissner L, Sjostrom L . Are elevated aminotransferases and decreased bilirubin additional characteristics of the metabolic syndrome?. Obes Res. 1997; 5(2):105-14. DOI: 10.1002/j.1550-8528.1997.tb00650.x. View

14.

Silvestre V, Ruano M, Dominguez Y, Castro R, Garcia-Lescun M, Rodriguez A . Morbid obesity and gastric bypass surgery: biochemical profile. Obes Surg. 2004; 14(9):1227-32. DOI: 10.1381/0960892042387048. View

15.

Lindroos A, Lissner L, Sjostrom L . Validity and reproducibility of a self-administered dietary questionnaire in obese and non-obese subjects. Eur J Clin Nutr. 1993; 47(7):461-81. View

16.

Sjostrom L, Larsson B, Backman L, Bengtsson C, Bouchard C, Dahlgren S . Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state. Int J Obes Relat Metab Disord. 1992; 16(6):465-79. View

17.

Del Genio F, Del Genio G, de Sio I, Marra M, Alfonsi L, Finelli C . Noninvasive evaluation of abdominal fat and liver changes following progressive weight loss in severely obese patients treated with laparoscopic gastric bypass. Obes Surg. 2009; 19(12):1664-71. DOI: 10.1007/s11695-009-9891-x. View

18.

Sjostrom L, Lindroos A, Peltonen M, Torgerson J, Bouchard C, Carlsson B . Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004; 351(26):2683-93. DOI: 10.1056/NEJMoa035622. View

19.

Wolf A, Beisiegel U . The effect of loss of excess weight on the metabolic risk factors after bariatric surgery in morbidly and super-obese patients. Obes Surg. 2007; 17(7):910-9. DOI: 10.1007/s11695-007-9169-0. View

20.

Kotronen A, Yki-Jarvinen H, Mannisto S, Saarikoski L, Korpi-Hyovalti E, Oksa H . Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. BMC Public Health. 2010; 10:237. PMC: 2873937. DOI: 10.1186/1471-2458-10-237. View